Mersana Therapeutics Inc. (MRSN) Financial Statements (2025 and earlier)

Company Profile

Business Address 840 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments174,561128,885177,947255,09499,79070,131
Cash and cash equivalents174,561128,885177,947255,09462,35159,634
Short-term investments     37,43910,497
Receivables 30,000   459
Other undisclosed current assets39,496160,33410,9513,4861,5363,715
Total current assets:214,057319,219188,898258,580101,32674,305
Noncurrent Assets
Operating lease, right-of-use asset7,69410,47512,88910,9362,598
Property, plant and equipment  3,9851,9681,7302,1642,694
Restricted cash and investments      
Other noncurrent assets4786612,3562,1531,4531,503
Other undisclosed noncurrent assets3,831     
Total noncurrent assets:12,00315,12117,21314,8196,2154,197
TOTAL ASSETS:226,060334,340206,111273,399107,54178,502
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities29,21757,13541,03724,48616,28223,102
Accounts payable7,31913,95112,3218,3407,29610,727
Accrued liabilities21,89843,18428,71616,1468,98612,375
Deferred revenue28,14730,6103,9443,9874,815
Debt4,310240239932,886 
Deferred rent credit      127
Other liabilities9389902399387 
Contract with customer, liability46,196
Other undisclosed current liabilities1,0252,5582,0641,344  
Total current liabilities:63,63791,53347,52330,00324,07069,425
Noncurrent Liabilities
Long-term debt and lease obligation23,14824,92935,87315,1354,878 
Long-term debt, excluding current maturities23,14824,92924,6264,9774,201 
Liabilities, other than long-term debt102,371125,821974174275282
Deferred revenue97,167117,043   
Deferred rent credit      282
Other liabilities55203974174275 
Operating lease, liability5,1498,57511,24710,158677
Total noncurrent liabilities:125,519150,75036,84715,3095,153282
Total liabilities:189,156242,28384,37045,31229,22369,707
Equity
Equity, attributable to parent36,90492,057121,741228,08778,3188,795
Common stock12117753
Additional paid in capital863,242746,889572,213508,499270,662172,966
Accumulated other comprehensive income (loss)11(152)  25(8)
Accumulated deficit(826,361)(654,691)(450,479)(280,419)(192,374)(164,166)
Total equity:36,90492,057121,741228,08778,3188,795
TOTAL LIABILITIES AND EQUITY:226,060334,340206,111273,399107,54178,502

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues36,85526,5814382842,12310,594
Gross profit:36,85526,5814382842,12310,594
Operating expenses(216,525)(230,348)(168,901)(88,938)(72,323)(76,249)
Operating loss:(179,670)(203,767)(168,858)(88,110)(30,200)(65,655)
Nonoperating income (expense)8,000(445)(1,202)651,9921,398
Investment income, nonoperating12,0732,883654242,226 
Interest and debt expense(4,073)(3,328)(1,267)(359)(234) 
Loss from continuing operations before equity method investments, income taxes:(175,743)(207,540)(171,327)(88,404)(28,442)(64,257)
Other undisclosed income from continuing operations before income taxes      
Loss from continuing operations before income taxes:(175,743)(207,540)(171,327)(88,404)(28,442)(64,257)
Income tax expense      
Loss from continuing operations:(175,743)(207,540)(171,327)(88,404)(28,442)(64,257)
Loss before gain (loss) on sale of properties:(171,327)(88,404)(28,442)(64,257)
Other undisclosed net income4,0733,3281,267359234 
Net loss:(171,670)(204,212)(170,060)(88,045)(28,208)(64,257)
Other undisclosed net income attributable to parent      
Net loss available to common stockholders, diluted:(171,670)(204,212)(170,060)(88,045)(28,208)(64,257)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(171,670)(204,212)(170,060)(88,045)(28,208)(64,257)
Other comprehensive income (loss)  (152) (25)33141
Comprehensive loss:(171,670)(204,364)(170,060)(88,070)(28,175)(64,116)
Other undisclosed comprehensive income, net of tax, attributable to parent163     
Comprehensive loss, net of tax, attributable to parent:(171,507)(204,364)(170,060)(88,070)(28,175)(64,116)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: